1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA HNRNPH3 CTRPv2 pan-cancer AAC -0.13 0.0004
mRNA ARL2BP CTRPv2 pan-cancer AAC -0.13 0.0004
mRNA DZIP3 CTRPv2 pan-cancer AAC -0.13 0.0004
mRNA CSTA CTRPv2 pan-cancer AAC 0.14 0.0004
mRNA C1orf74 CTRPv2 pan-cancer AAC 0.13 0.0004
mRNA ENTPD2 CTRPv2 pan-cancer AAC 0.13 0.0004
mRNA THAP9 CTRPv2 pan-cancer AAC -0.13 0.0004
mRNA PARP2 CTRPv2 pan-cancer AAC -0.13 0.0004
mRNA KIF13B CTRPv2 pan-cancer AAC 0.13 0.0004
mRNA TMEM45B CTRPv2 pan-cancer AAC 0.13 0.0004
Download CSV